Medical News Update
- Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 09/16/2026
- Registered Outsourcing Facilities
- CDER Nitrosamine Impurity Acceptable Intake Limits
- What's New Related to Drugs
- Oncology (Cancer)/Hematologic Malignancies Approval Notifications
- FDA approves belzutifan in combination with lenvatinib for advanced renal cell carcinoma with a clear cell component
- Zenzi Pharmaceutical Industries Private Limited - 701130 - 09/18/2026
- Zenzi Pharmaceutical Industries Pvt. Ltd. - 701130 - 02/13/2025
- Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023
- FDA Public Meeting: FDA-Led Patient-Focused Drug Development Meeting for Nonhealing Chronic Wounds - 08/25/2026
- Drug Supply Chain Security Act (DSCSA) Assessment of Small Dispensers
- Generic Drug Facilities, Sites and Organization Lists
- BsUFA IV: Fiscal Years 2028-2032
- Notable Approvals | Drugs
- FDA Approves Once-Weekly Insulin for Type 2 Diabetes Mellitus
- Drugs@FDA Data Files
- CDER Small Business & Industry Assistance (SBIA)
- Communicating Drug Interaction and QTc Information in the U.S. Prescribing Information - 09/23/2026
- FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma
- Condition-Specific Meeting Reports and Other Information Related to Patients' Experience